Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

Abstract

NSAID use is inversely associated with AD and may be modified by APOE genotype. Prospective studies and clinical trials of sufficient power to detect effect modification by APOE-epsilon4 carrier status are needed.